Alanya Alaaddin Keykubat University   Report issue

Academic/Hospital Phase 3
Founded: Alanya Turkey (2015)

Organization Overview

First Clinical Trial
2019
NCT04044131
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Alaaddin Keykubat University | Alanya Alaaddin Keykubat University | Alanya Alaaddin Keykubat University Alanya Training and Research Hospital

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alzheimer Disease (Phase 2)

Parkinson Disease (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 6